Instruction for Authors
Aims and scope:
The Tanaffos journal, a scientific and research peer reviewed journal, seeks to publish original papers, review articles, case reports and other articles of special interest related to the field of respiratory diseases, thoracic surgery, intensive care and tuberculosis. The journal is an official publication of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) Shahid Beheshti University of Medical Sciences, and is published quarterly. The journal seeks to provide its readers with the highest quality materials published through a process of careful peer reviews and editorial comments. All papers are published in English. The editor requires that authors provide a cover letter in which they state their written assurance of the following:
1) The submitted paper is an original and unpublished work in which the listed authors have all made important contributions.
2) The authors have not submitted the same material or portions thereof for consideration of publication in any other journal for which a decision regarding publication is pending, and no such additional submission will be made before completion of the review process by Tanaffos Journal.
3) The authors must further guarantee that once their material has been accepted for publication by the Journal, they will not make submission of the same material or portions thereof to another journal before publication in Tanaffos Journal. After receiving the manuscript, it would be evaluated and reviewed by two or three reviewers. The final decision to accept manuscripts rests with the Editorial Committee of the Tanaffos Journal. Acceptance of manuscripts for publication depends on their quality, originality, clarity, and relevance to the journals scope. Rejected manuscripts will be held for a limited period of time and then expired.
We are delighted to consider manuscripts for publication from scholars all over the world.
The Editorial Process
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Tanaffos Journal alone at that point of time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the readers ofTanaffos Journal are also liable to be rejected at this stage itself.
Manuscripts that are found suitable for publication in Tanaffos Journal are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author should be the uploading author and is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process, from submission of the manuscript to final decision and sending and receiving proofs is completed online.
Peer review process:
All manuscripts are considered to be confidential. They are peer-reviewed by at least 2 anonymous reviewers selected by the Editorial Board. The corresponding author is notified as soon as possible of the editor decision to accept, reject, or require modifications. If the manuscript is completely acceptable according to the criteria set forth in these instructions, it is scheduled for the next available issue.
Page charges: There are no charges for publication in this Journal.
Authorship credit should be based only on substantial contributions based on authorship criteria of international committee of medical journal editors: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html
Information for Authors
Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journal" developed by international committee of medical Journal Editors: http://www.icmje.org/about-icmje/faqs/icmje-recommendations/
Original Research Articles: Reports of original research that are novel and well-documented are the main interest of Tanaffos. These manuscripts must be organized into eight parts: (1) Structured Abstract (Background and Aim, Materials and Methods, Results, Conclusion); (2) Introduction; (3) Materials and Methods; (4) Results; (5) Discussion; (6) Conclusion; (7) Acknowledgement; (8) References
Review Articles: These manuscripts are usually written by experts in the field who have been invited by the Editorial Board. The Editor in Chief may request a renowned researcher to write a review article on a specific topic exclusively for Tanaffos. Authors of such review articles must provide at least three citations to their previous published work on the topic to be reviewed. Review articles must be comprehensive and authoritative and must meet the scope of the journal.
Systematic Reviews and Meta-Analyses: Manuscripts that review the current status of a given topic, diagnosis, or treatment. These manuscripts should not be an exhaustive review of the literature but rather should review a contemporary thought with respect to the topic. Systematic reviews and meta-analyses manuscripts should follow PRISMA ( http://www.prisma-statement.org) and the Institute of Medicines' guidelines ( http://www.iom.edu/Reports/2011/Finding-What-Works-in-Health-Care-Standards-for-Systematic-Reviews/Standards.aspx).
Case Reports/Case Series: Reports of clinical cases that can be educational may qualify for publication in Tanaffos. Case reports/series must describe a diagnostic or therapeutic dilemma or very rare cases. Authors should thoroughly explain the process of diagnostic work up and treatment and briefly review the available literature. Clinical relevance or implications of the case must be discussed as well. All case report articles should indicate that written informed consent to publish the information has been obtained from the patients or their legal guardians. Case reports must meet the followings in order to become qualified for publication: (1) rare or unusual cases that need documentation, (2) well-documented cases showing unusual or "atypical" clinical or microscopic features or (3) cases showing good long-term follow-up information, particularly in areas in which good statistics on results of treatment are lacking. Case reports must be organized into four parts: (1) Abstract (Introduction, Case presentation, Conclusion), (2) Introduction, (3) Case Presentation, and (4) Discussion.
Commentaries: These articles are short articles on any subject within the scope of the journal written by opinion leaders and are related to contemporary issues, such as recent research findings.
Letter to the Editor: These manuscripts may do a re-analysis of a previously published article, may include a response to the authors of an original publication, or may be an article that does not meet the ‘standard research’ criteria but may be informative for readers.
All manuscripts must be submitted electronically through Website: http://www.Tanaffosjournal.ir in the section of submit manuscript
To submit online please follow on screen instructions and steps to upload different part of your article at the website. If the references have been prepared using Reference Manager software, EndNote, or similar programs, please ensure to remove the reference manager links from the file before submission. Otherwise these references may not be visible under certain platforms. All tables must be present in the main submission file and they may not embedded as graphics. All figures, pictures, graphics or images must be submitted as supplementary files in a format of JPEG, GIF or TIFF which will produce high quality images in the online edition of the journal. Manuscript must be accompanied by a covering letter to the Editor-in-Chief, including title and author(s) name and undertaking that it has not been published or submitted elsewhere.
To avoid unnecessary delays, authors should adhere strictly to the following instructions. Language: You may send your manuscript in English. Typing: All parts of manuscripts must be typed double-spaced in 10 or 12 print typeface, with margins of 2.5cm. Arrange the manuscript with the following components and begin each one on a new page: 1) Title page 2) Abstract and Keywords 3) Body of paper 4) References 5) Acknowledgements 6) Figure legends 7) Tables. Pages should be numbered consecutively.
There is no limitation in length of the articles submitted in Tanaffos journal for publishing.
General arrangement of papers:
Title page: The title page should contain the following information:
1) The full title of the manuscript, not to exceed 120 characters. No abbreviations are acceptable in the full title. If the work involves the use of an experimental model, the animal species involved must be included in the title.
2) The full names of all authors. Authors should be limited to those individuals contributed in an important manner to the study design, data collection and analysis, or writing of the paper.
3) The department and institution where the work has been performed, as well as the affiliations of the individual authors.
4) Grand support, indicating the source of any financial support for the study.
5) Name and address of the author to whom communication regarding the manuscript should be directed (The author who is responsible for correspondence) including an e-mail address.
6) A shortened version of the title that is 40 characters or less to be used as a running title. Abbreviations: When using abbreviations, write the full name of the abbreviated item followed by the abbreviation in parentheses at the point of first mention of the abbreviation within the body of the manuscript: e.g.,"bronchoalveolar lavage (BAL)". Do not use abbreviations in the abstract or title of the manuscript. Abbreviations may be used in figures and tables, but such abbreviations must be explained in the figure legend or a foot note to the table. When mentioning products such as medicines or equipments, use the generic name, followed by trade name, manufacture (er) name and location. For example:The patient was treated with bilevel nasal positive pressure (BiPAp; Respironics lnc; Murrysville, PA)
Original articles: Observational and experimental articles should conform to the usual structure of abstract, introduction, materials and methods, results, discussion, acknowledgements, references, tables and legends for figures. Subhead in case reports might include: Introduction, Case report, Discussion and Conclusion.
Abstract: Each article should be preceded by an abstract except Review Articles. The abstract must be limited to 250 words. Using abbreviations and footnotes in the body of the abstract must be avoided and references should not be cited here. An abstract includes a brief description of the background, materials and methods, results and conclusion of the study in the form of a structured abstract. Three to ten keywords or short phrases that reflect the content of the manuscript should be provided by the author(s) together with the abstract for indexing. They should be placed in alphabetical order and when possible, adjusted to the medical subject headings of Index Medicus. (MeSH).
Introduction: This should contain a description of the problem under investigation, reasons for doing the work and a brief survey of the existing literature on the subject.
Materials and Methods: Sufficient information must be included to permit repetition of experimental work. Correct chemical names should be given and strains of organisms should be specified. Suppliers of materials need only be mentioned if this may affect the results. Use System International (SI) units and symbols.
Results: This section should describe concisely data and findings of research and the rationale of the investigation and its outcomes. The use of tables and figures to illustrate the same results will only rarely be allowed. Tables and figures should be selected to illustrate specific points. Do not tabulate or illustrate points that can be adequately and concisely described in the text.
Discussion: This should not simply recapitulate the results. The presentation of results should be separated from a discussion of their significance. It should relate results to previous work and interpret them. Include within the body of the text a description of the ethical guidelines that were followed for human and animal studies. If appropriate, provide citation of institutional review by human or animal research committees. Also describe any hazardous procedures or chemicals involved in the studies and what precautions were taken to avoid injury to subjects or investigators. Within the methods section, provide a brief but complete description of the statistical methods used including which tests were done for analysis of which variables. Medicines, medication or other materials should be listed as generic items. If brand names are used, they should be placed after the generic name in parenthesis with manufacturers name, city, and State or country. Restrict all comments and discussion to the Discussion section. Randomized controlled trials should include patients informed consent form and the bioethics committee approval of the corresponding university.
Acknowledgements: This part should include a statement thanking those who assisted substantially with work relevant to the study. Besides personal acknowledgements, sources of financial support should be mentioned in this section, if required.
Cite references in text in order of appearance using Arabic numerals in parentheses for citations. Place the reference list at the end of the final text page. References should be listed in text citation number order and must be double-spaced. List all authors when six or fewer, when seven or more, list the first six and add "et al". Manuscripts accepted but not yet published can also be included in the references; designate the journal followed by "in press" (in parenthesis). References to unpublished material, such as personal communications and unpublished data, must be placed within the text and not cited in the References section. Personal communication and unpublished data must include the individuals name, location and month and year of communication as appropriate. Use Index Medicus abbreviations for journals that are indexed; if a journal is not indexed, use full name.
Following are examples of the most common formats:
Standard Journal article:
Miles M, Rodrigues A, Tajali S, Xiong Y, Orchanian-Cheff A, Reid WD, Rozenberg D. Muscle and cerebral oxygenation during cycling in chronic obstructive pulmonary disease: A scoping review. Chron Respir Dis 2021;18:1479973121993494.
Chapters in books:
Philips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995.p.465-78.
Each table should be typewritten with double spacing on a separate page and numbered in order of citation in the text with Arabic numerals. Each table should have a concise heading that makes it comprehensible without reference to the text of the article. Explain any nonstandard abbreviations in a footnote to the table.
Radiographs, CT Scans, ECGs and any other figures must be submitted in quadruplicate in a format suitable for direct reproduction in the journal. Do not send artwork, slides, etc. Appropriate formats include glossy photographs, high- resolution (300 dpi or greater) laser printer output or original artwork. Complete anonymity of patients is recommended. Please mask the eye region in photographs of patients.
Ethical considerations must be addressed in the Materials and Methods section. 1) In the case of clinical trials: Authors should comply with the clinical trial registration statement from the ICMJE. More information can be found at WWW.icmje.org. Clinical trial reports should also comply with the consolidated Standards of Reporting Trials (CONSORT) and include a flow diagram presenting the enrollment, intervention allocation, follow – up, and data analysis with number of subjects for each (www.consort – statement.org). Please also refer specifically to the CONSORT Checklist of items to include when reporting a randomized clinical trial.
2) When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the last update of Helsinki Declaration (http://www.icmje.com). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.
3) Indicate in the text that the maintenance and care of experimental animals complies with National Institutes of Health guidelines for the humane use of laboratory animals, or those of your Institute or agency.
Tanaffos Journal condemn and criticize the efforts of plagiarism. The journal follows strictly the norms of ethics and sanctity of academics. The Editorial Board checks thoroughly plagiarism of each and every article. Hence the authors are advised not to submit plagiarized articles. Plagiarized articles in any form (be it copying the text or figures from literature or internet journal or some published articles without quoting proper references etc.) will be rejected.
Conflicts of Interest:
Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in, an organization that may profit or lose through publication of your paper. Declaring a competing interest will not lead to automatic rejection of the paper, but we would like to be made aware of it.
Papers may be returned to authors for modification of the scientific content and / or for shortening and language corrections recommended by reviewers. Revised versions must be submitted to the editor and must be accompanied by a copy of the original version and by a latter listing the changes that have been made. The revised manuscript will be sent to the reviewers again to see if their opinions have been applied.
Proofs will be sent to the corresponding author to be checked for only typographical errors and other essential small changes. Major alterations to the text cannot be accepted at this stage. Proofs must be returned to the Editor within 3 days of receipt.
This agreement is made with the Tanaffos Journal. The agreement is for the Article submitted by you ("Author") for publication in the Tanaffos Journal. To enable publishing the Article in the Journal, the ownership of copyright must be established. The author should read and complete the form and return one copy to the journal office. There are explanatory notes to this Agreement, which also form a part of the agreement. In consideration of publication of the article in the Journal, I hereby warrant and undertake 1) That this article is an original work has not been published before and is not being considered for publication, elsewhere; b) That I have obtained permission from the copyright holder to reproduce in the Article (print,…); c) That this article contains no violation of any existing copyright or other third party right; d) That I will indemnify and keep indemnified the Editors of the Tanaffos Journal against all claims and expenses, arising from any breach of this warranty. e) That in the case of a multi-authored Article I have obtained copyright assignment from all co-authors. I hereby assign to Tanaffos Journal copyright for the full period of copyright and all renewals, extensions, revisions and revivals together with all rights of action throughout the world in any form and in any language.